Joe Dillon, Ph.D., MBA, is a seasoned executive with extensive experience in the medical, biotech, and pharmaceutical industries. Currently serving as President and CEO of Dillon Capital Strategies since December 2008, Joe focuses on strategy and business analytics consulting. In addition, Joe is the Chief Business Officer at Laminar Pharma, which specializes in Membrane Lipid Therapy, and collaborates with Rallybio on valuations and deal structuring. Previous roles include CEO of BioPact, Senior Vice President at The Mattson Jack Group, and interim CEO at Pharmaceutical Development Center. Joe's educational background includes a Ph.D. in Metaphysical Sciences and an MBA in International Finance, along with a BBA in Finance.
This person is not in the org chart
This person is not in any teams
This person is not in any offices